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Abstract
Taurine (TAU) is a β-amino sulfonic acid with pleiotropic roles in the brain, including the neuromodulatory activity via
GABAergic and glycinergic agonism. This molecule is found at high concentrations in energy drinks and is often mixed
with alcohol in beverages. Although TAU has a neuroprotective role in the brain, the putative risks of mixing TAU and
EtOH are not fully understood. Here, we investigated whether TAU modulates locomotor and anxiety-like behavior in
adult zebrafish by using the novel tank and light-dark tests following acute EtOH exposure at anxiogenic and anxiolytic
concentrations. Zebrafish were individually exposed to water (control), TAU (42, 150, and 400 mg/L), and EtOH (0.25%
(v/v) and 1% (v/v)) both independently and cotreated for 1 h. EtOH 0.25% and TAU produced U-shape anxiolytic-like
behavior in the light-dark test, TAU 42 and 400 positively modulated EtOH effects, and TAU 150 exerted a protective
effect. All TAU concentrations counteracted EtOH 1%-induced locomotion impairment, as well as the anxiogenic-like
behavior. Finally, all TAU concentrations when given independently or cotreated with EtOH 0.25% and 1% decreased the
risk assessment of the lit compartment. Principal component analyses revealed that exploration and anxiety-like responses
were the main behaviors that contribute to the effects of TAU and EtOH. Overall, we demonstrate that TAU differently
modulates EtOH-induced anxiolytic- and anxiogenic-like behaviors depending on the concentration, suggesting a complex
mechanism underlying TAU and EtOH interactions.
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Introduction
Ethanol (EtOH) is one of the most widely consumed psy-
choactive drugs worldwide (Degenhardt et al. 2008). EtOH
acutely promotes a biphasic effect, where low to moderate
doses are stimulant and higher doses induce depressant
effects (Addicott et al. 2007). In the brain, the mechanisms
underlying the effects of EtOH include neuroinflammation,
glial effects, and impaired neuromodulation (Lasek 2016;
Montesinos et al. 2016). Furthermore, alcohol has stress-
reducing properties, and the chronic use can escalate into
alcohol use disorders (Cooper et al. 1995; Schroder and
Perrine 2007), which frequently comorbid with anxiety-
related disorders (Grant et al. 2004; Kushner et al. 1990).
Patients with mood and anxiety disorders use substances to
cope with the negative symptoms associated with the dis-
eases, thereby corroborating a high correlation between
anxiety and alcohol use disorder. Then, increased alcohol
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consumption for a long period can facilitate substance use
disorder (Turner et al. 2018).
Taurine (TAU) is a β-amino sulfonic acid found at high
concentrations in energy drinks (Heckman et al., 2010) and
is commonly mixed with alcohol in several popular beverages
(Ferreira et al. 2004a; Ferreira et al. 2004b; Marczinski and
Fillmore 2014). This molecule acts as osmotic regulator
(Schaffer et al. 2010), membrane stabilizer (Lambert et al.
2015), antioxidant (Lerdweeraphon et al. 2013), and inhibito-
ry neuromodulator (Wu and Prentice 2010), as well as in the
maintenance of intracellular calcium metabolism (Foos and
Wu 2002). Although most studies do not investigate the direct
interaction of TAU/EtOH, the combined used of EtOH and
energy drinks is associated to major health problems. Thus,
the combined use of alcohol and energy drinks increases the
number and time of drinks consumed, dehydration, and more
severe and prolonged hangovers, leading to an increase num-
ber of alcohol poisoning reports (Patrick et al. 2014; Snipes
and Benotsch 2013).
TAU modulatory activity has been shown to regulate
distinct behaviors, causing a negative impact when associ-
ated with drugs of abuse depending on the concentration
(Fontana et al. 2016; Fontana et al. 2018; Mezzomo et al.
2018). For example, high concentrations of TAU associat-
ed to alcohol can increase aggressive behavior (Fontana
et al. 2016) and decrease seeking for conspecifics
(Fontana et al. 2018) in zebrafish. The hypothesis under-
lying the negative interaction of TAU with alcohol sug-
gests an involvement of GABAA, where both molecules
have an agonist role (Huxtable 1992; Olsen and Liang
2017; Wallner and Olsen 2008). Because the GABAergic
system is involved in anxiety-related disorders (Lydiard
2003; Tasan et al. 2011) and considering that EtOH and
TAU are concomitantly found in alcohol beverages, the
study of their association is relevant to better understand
how the interaction between these molecule can affect
anxiety-related phenotypes in vertebrate systems.
The zebrafish (Danio rerio) is a suitable model species
for modeling human diseases due to its high genetic and
physiological homology, as well its well-characterized be-
havioral repertoire (Fontana et al. 2018; Kalueff et al.
2013; Parker et al. 2012; Stewart et al. 2015). Although
EtOH and TAU alone modulate locomotion and anxiety-
like behaviors in zebrafish (Gerlai et al. 2000; Mezzomo
et al. 2016), the influence of their cotreatment in anxiety-
like phenotypes has been poorly explored. Thus, we aimed
to evaluate the role of TAU and EtOH (low and high con-
centrations) in modulating anxiety-like responses in
zebrafish using two behavioral tests (novel tank and
light-dark tests). Using the principal component analysis
(PCA), we also assessed which parameters have more im-




Adult zebrafish (Danio rerio) (50:50 male: female ratio; wild-
type; short fin phenotype) were obtained from a commercial
supplier (Hobby Aquários, RS, Brazil). Animals were main-
tained for 2 weeks in 50 L tanks filled with non-chlorinated
water at a density of two animals per liter under controlled
temperature (26 ± 2 °C), pH (7.0–7.5), and photoperiod cycle
(14:10 light-dark; lights on at 7:00 a.m.). Fish were fed twice
daily with commercial flake food (Alcon Basic®, Alcon,
Brazil). All behavioral tests were performed during the same
time each day (between 10:00 a.m. and 4:00 p.m.) immediate-
ly after TAU or/and EtOH exposure. Importantly, two inde-
pendent batches were used for the experiments, and each an-
imal was tested in a single apparatus (novel tank or light-dark
test) to avoid stress caused by subsequent manipulations. The
tank water was changed after each trial to remove potential
cues that influence behavior. Both housing and experimental
conditions were in accordance to the National Institute of
Health Guide for Care and Use of Laboratory Animals. All
protocols used in this study were previously approved by the
Ethics Commission on Animal Use of the Federal University
of Santa Maria (process number 026/2014).
Treatments
To assess the effects of TAU (Sigma, St. Louis, MO, USA)
and EtOH (Merck, Darmstadt, Germany) association, fish
were exposed individually in 500 mL beakers for 1 h. The
following groups were tested: control (non-chlorinated water),
TAU alone at 42 mg/L (TAU 42), 150 mg/L (TAU 150), and
400 mg/L (TAU 400) and EtOH 0.25% (v/v) alone or
cotreated with TAU (TAU 42/EtOH 0.25%, TAU 150/EtOH
0.25%, and TAU 400/EtOH 0.25%) and EtOH 1% (v/v) alone
or cotreated with TAU (TAU 42/EtOH 1%, TAU 150/EtOH
1%, and TAU 400/EtOH 1%). TAU concentrations were
based on previous reports, which showed anxiolytic-like prop-
erties, as well as a significant modulatory role on EtOH-
induced behaviors (Fontana et al. 2016; Mezzomo et al.
2016; Rosemberg et al. 2012). In order to assess both
anxiolytic- and depressant-like effects of alcohol in zebrafish,
two concentrations (0.25% v/v and 1% v/v) were chosen as
described elsewhere (Gerlai et al. 2000). A total of 288 fish
were used for the experiments.
Novel tank diving test
The novel tank diving test is one of the most used apparatus to
assess locomotor and anxiety-like phenotypes, showing a high
sensitivity to anxiolytic and anxiogenic manipulations (Egan
et al. 2009; Kalueff et al. 2013; Levin et al. 2007; Maximino
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et al. 2010b; Mezzomo et al. 2016; Wong et al. 2010). After
the exposure period, animals (n = 10–12) were placed indi-
vidually in the apparatus (25 cm length x 15 cm height x 6 cm
width). Behaviors were recorded using a webcam for 6 min
based on previous studies, where animals gradually spend
more time in the top portion of a tank over the first 6 min of
the test (Blaser and Rosemberg 2012; Egan et al. 2009;
Mezzomo et al. 2016; Rosemberg et al. 2012; Wong et al.
2010). Data were analyzed in an automated fashion using a
video-tracking software (ANY-mazeTM, Stoelting CO, USA)
at a rate of 30 frames/s. The tank was divided in three virtual
areas (bottom, middle, and top) to provide a detailed evalua-
tion of the vertical activity. The following endpoints were
measured: total distance traveled, absolute turn angle, latency
to enter the top area, time spent in top area, transitions to top
area, and immobility.
Light-dark test
The light-dark test is a complementary task to assess
anxiety-like responses, which explores the natural tenden-
cy of adult zebrafish to avoid brightly lit environments
(Blaser and Rosemberg 2012; Maximino et al. 2010a;
Maximino et al. 2010b; Rosemberg et al. 2011). This test
was performed in experimental tanks (30 cm length x
10 cm width x 15 cm height) divided into two equally sized
partitions using black or white self-adhesive film to cover
the walls and floor. After the treatments, zebrafish (n = 10–
12) were gently placed in the white partition of the tank,
and their behaviors were quantified for 6 min using the
ANY-mazeTM software (Stoelting CO, USA) at a rate of
30 frames/s. The following endpoints were determined:
time spent in lit area, transitions to lit area, latency to enter
the dark area, and number of risk assessment episodes.
Risk assessment was assessed manually by three trained
observers blinded to the experimental condition (inter-rater
reliability > 0.90) and defined as a fast (>1 s) entry in the
white compartment followed by reentry in the black com-
partment, or as a partial entry in the lit area (Kalueff et al.
2013; Mezzomo et al. 2016).
Statistics
Data were checked for normality and homogeneity of vari-
ances via the Kolmogorov-Smirnov and Bartlett’s tests, re-
spectively. Data were expressed as means ± standard error of
the mean (S.E.M) and further analyzed by two-way or three-
way ANOVA followed by Tukey’s multiple comparisons test.
Given the asymmetric data distribution of the latencies to enter
to the top/dark areas, the respective parameters were
expressed as median ± interquartile range and analyzed by
Kruskal-Wallis test followed by Dunn’s multiple comparison
test. PCAwas performed to evaluate the potential correlation
between variables of the novel tank diving task and the light-
dark test, separately. The component matrix was subjected to
Varimax rotation with Kaiser normalization. Components (or
factors) with eigenvalue lower than 1 were disregarded, and
measures with loadings greater than 0.4 were retained. The
first principal component (PC1) explains the largest percent-
age of data variance. Data were analyzed in SPSS 19 (IBM
SPSS Statistics, version 19). Post hoc analyses were per-
formed using Tukey’s multiple comparisons test when appro-
priate. The significance was set at p ≤ 0.05.
Results
TAU counteracts EtOH-induced locomotor deficits
and anxiogenic-like behavior
Figure 1 shows the effects of TAU and EtOH in the novel tank
task. Two-way ANOVA yielded a significant EtOH effect on
distance traveled (F(2,116) = 18.51, p < 0.0001), absolute turn
angle (F(2,116) = 67.65, p < 0.0001), and transitions to top area
(F(2,116) = 33.04, p < 0.0001). Furthermore, a significant TAU
× EtOH interaction was observed for the time spent in top
(F(6,116) = 3.070, p = 0.0081) and transitions to top area
(F(6,116) = 4.090, p = 0.0009). TAU 42 (p < 0.005) and 150
mg/L (p < 0.005) alone increased the latency to enter the top
area, while EtOH 0.25% alone did not show significant dif-
ferences in the novel tank test when compared with control.
Regarding the effects of EtOH 1%, only EtOH 1% and TAU
150/EtOH 1% groups showed a reduced distance traveled.
Additionally, EtOH 1% alone and all TAU-associated groups
showed decreased absolute turn angle and transitions to top
area, except TAU 400/EtOH 1%, which revealed only a de-
creased absolute turn angle. Animals exposed to 1% EtOH
alone spent less time in top area, but this effect was abolished
by all TAU concentrations. Temporal analyses of the time
spent in the top area showed that EtOH significantly affected
the diving responses across time (F(10,116) = 4.634, p <
0.0001). Finally, a significant interaction of time × TAU ×
EtOH was observed (F(30,116) = 1.647, p = 0.017) (data not
shown).
TAU induces biphasic reduction of anxiolytic-like
behavior
Figure 2 shows the behavioral responses of zebrafish in the
light-dark test. Significant TAU effects were observed in the
time spent in lit area (F(3,122) = 2.404, p = 0.0440) and risk
assessment episodes (F(3,122) = 11.43, p < 0.0001). Significant
EtOH effects were observed for the time spent in lit area
(F(2,122) = 12.99, p < 0.0001), average duration of entry in
the lit area (F(2,122) = 4.233, p = 0.0167), and risk assessment
episodes (F(2,122) = 48.57, p < 0.0001). Furthermore, a TAU ×
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EtOH interaction was observed for both time spent in lit area
(F(6,122) = 2.404, p = 0.0313) and risk assessment episodes
(F(6,122) = 4.403, p = 0.0004). The effects of TAU alone in the
light-dark test revealed that TAU 42 and TAU 400 groups
spent more time in the lit area. Regarding EtOH 0.25% effects,
EtOH alone increased the time spent in lit area. Two-way
ANOVA revealed that EtOH 1%, TAU42/EtOH 1%, and
TAU400/EtOH 1% groups spent more time in the lit area.
Additionally, TAU groups (alone or concomitantly exposed
to alcohol) showed decreased number of risk assessments.
Temporal analyses yielded a significant time × TAU × EtOH
interaction (F(30,122) = 2.431, p = 0.000), while only EtOH
modulated the light-dark responses across time (F(10,122) =
1.968, p = 0.034).
Fig. 2 Effects of TAU and/or EtOH in the light-dark test. Data were represented as mean ± S.E.M. and analyzed by two-way ANOVA, followed by
Tukey’s multiple comparison test. Different letters indicate statistical differences between groups (p < 0.05, n = 12 per group)
Fig. 1 Effects of TAU and/or EtOH in the novel tank task. Data were represented as mean ± S.E.M. and analyzed by two-way ANOVA, followed by
Tukey’s multiple comparison test. Different letters indicate statistical differences between groups (p < 0.05, n = 12 per group)
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Exploratory- and anxiety-related parameters are
the main components involved in the behavioral
responses measured
Figure 3 and 4 show the main components driving the
behavioral responses of zebrafish when exposed to TAU
or/and EtOH in the novel tank and light-dark test, respec-
tively. For novel tank and light-dark tests, the Kaiser-
Meyer-Olkin measure of sampling adequacy were 0.700
and 0.512, respectively. Bartlett’s tests of sphericity were
also significant for novel tank task (χ2 = 244.236, df = 15,
p < 0.000) and light-dark test (χ2 = 36.883, df = 10, p <
0.0001).
In the novel tank task, PCA extracted two principal com-
ponents which accounted for more than 63% of the total var-
iance (Fig. 3A). PC1 was associated with locomotion and
exploratory activity, with positive component loadings for
distance traveled, angular velocity, transitions to top, and a
negative component loading for immobility. Meanwhile, the
PC2 was associated with anxiety-related parameters, with a
negative component for time spent in top and a positive com-
ponent for latency to enter in top area. Two-way ANOVA
yielded significant effects of TAU × EtOH interaction
(F(6,116) = 3.332, p = 0.0044), TAU (F(3,116)= 3.582, p =
0.0158), and EtOH (F(2,116)= 33.20, p = 0.0001) for the PC1.
Post hoc analysis showed that EtOH 1% significantly affect
the PC1, showing reduced values when concomitantly ex-
posed with TAU 400 mg/L. For the PC2, a significant TAU
× EtOH interaction (F(6,116)= 2.584, p = 0.0215) was observed,
in which TAU 150 vs TAU 150 + EtOH 1% showed signifi-
cant differences.
In the light-dark test, PCA extracted two principal compo-
nents accounting for 60% of the total variance (Fig. 4A). PC1
was highly associated to anxiety-related parameters, in which
the time spent in lit area was loaded as a positive component,
while the average duration of entry in lit area and the risk
assessment were loaded as negative components. PC2 was
associated to exploratory patterns in the light-dark test, load-
ing a positive component for transitions in lit area and a neg-
ative one for latency to enter the dark area. Significant TAU ×
EtOH interaction (F(6,122) = 18.51, p = 0.0001), TAU (F(3,122)=
16.80, p = 0.0001), and EtOH (F(2,122)= 63.26, p = 0.0001)
effects were observed for the PC1 analysis. Post hoc analysis
yielded a significant increase of PC1 values for TAU, EtOH
0.25%, EtOH 1% alone, and TAU-associated groups when
compared to the control (Fig. 4B).
Fig. 3 Principal component analysis (PCA) for behavioral endpoints
measured in the novel tank test. (A) Correlation coefficients between
the behavioral endpoints for each PC. Dashed lines represent cut-off
points, and only loadings greater than 0.3 or smaller than −0.4 are
depicted. (B) Comparison of the values of two PC with eigenvalues
greater than 1. Data are expressed as mean ± SEM and analyzed by
two-way ANOVA, followed by Tukey’s post hoc test. Distinct letters
indicate statistical differences between experimental groups (p < 0.05, n
= 12 per group)
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Discussion
In this study, we evaluated the concomitant effects of TAU-
and EtOH-induced changes in anxiety-like behaviors. We
have shown for the first time that TAU attenuates EtOH-
induced locomotor and anxiogenic-like phenotypes in the
novel tank test. Moreover, when associated with EtOH, TAU
results in a U-shaped response in light-dark test, exerting an
anxiolytic-like effect in the lowest and highest concentrations,
with a preventive effect at 150 mg/L. Moreover, all TAU con-
centrations tested decreased the risk assessment to lit
compartment.
EtOH is an anxiolytic molecule at lower concentrations. In
humans, for example, alcohol may be consumed to counteract
acute social anxiety, and this reinforcing effect can even in-
crease future use with EtOH acting as a “social reward”
(Goodman et al. 2018). The mechanisms underlying the bi-
phasic effects of alcohol in anxiety-related behaviors include
the antagonism of glutamatergic receptors and the increase in
dopamine and serotonin (5-HT) levels (Alasmari et al. 2018;
Deehan et al. 2016). Additionally, high EtOH concentrations
positively modulate GABAA and GABAB receptors (Frye and
Fincher 1996; Krystal et al. 2003; Olsen and Liang 2017). As
observed previously (Gerlai et al. 2000), EtOH 0.25% showed
anxiolytic-like effects in the light-dark test. Conversely, EtOH
1% altered exploration, showing anxiogenic-like responses in
the novel tank test (Blaser and Penalosa 2011; Gebauer et al.
2011; Gerlai et al. 2000; Rosemberg et al. 2012; Tran and
Gerlai 2013). However, the same EtOH concentration in-
creased the time spent in lit area in the light-dark test. High
alcohol concentrations can affect motor function and visual
perception (Calhoun et al. 2004; Nutt and Peters 1994). In
fact, EtOH 1% has been associated to changes in perception
(Gerlai et al. 2000; Oliveira et al. 2013). Corroborating these
findings, we observed that high EtOH concentrations signifi-
cantly decreased the PC1 in the novel tank suggesting an
impairment in their locomotor profile. Thus, the conflicting
data observed in the light-dark test could be related to reduced
swimming activity and/or even changes in visual perception
when zebrafish are tested in a tank with two different contexts.
TAU alone displayed an anxiolytic profile at the 42 and 400
mg/L without modulating EtOH-induced responses. TAU has
anxiolytic-like effects when zebrafish behavior is assessed in
the novel tank and in the light-dark tests (Mezzomo et al.
2016). Similar concentration-dependent responses were also
previously described, where TAU potentiates EtOH-increased
Fig. 4 Principal component analysis (PCA) for behavioral endpoints
measured in the light-dark test. (A) Correlation coefficients between the
behavioral endpoints for each PC. Dashed lines represent cut-off points
and only loadings greater than 0.3 or smaller than − 0.4 are depicted. (B)
Comparison of the values of two PCwith eigenvalues greater than 1. Data
are expressed as mean ± SEM and analyzed by two-way ANOVA,
followed by Tukey’s post hoc test. Distinct letters indicate statistical dif-
ferences between experimental groups (p < 0.05, n = 12 per group)
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aggression at the lowest and highest concentration, while 150
mg/L displays anti-aggressive action (Fontana et al. 2016).
Although TAU changed anxiety-like profiles at the lowest
and highest concentration, TAU 150 mg/L prevented
anxiolytic-like effects of alcohol at 0.25% and decreased
EtOH 1%-induced changes in the light-dark test. All TAU
concentrations alone and associated to EtOH also decreased
the number of risk assessment episodes. The reduction of risk
assessment episodes was previously observed in a fear-related
task, where animals showed less caution when exploring the
compartment close to a predator (Fontana et al. 2018).
Moreover, the lowest and highest concentrations protected
against EtOH 1%-induced locomotor impairment. As ob-
served here, mounting evidence shows that TAU does not
change locomotion (Fontana et al. 2016; Fontana et al. 2018;
Mezzomo et al. 2016; Rosemberg et al. 2012). In zebrafish,
TAU pretreatment decreases alcohol content in the brain and
prevents EtOH-induced locomotor changes, suggesting a di-
rect influence of EtOH levels in the locomotion (Rosemberg
et al. 2012). Additionally, TAU counteracts EtOH-induced
anxiogenesis by normalizing the transitions and time spent
in top area, only at the highest concentration. TAU is a mole-
cule endogenously produced through cysteine oxidation hav-
ing important physiological role in living organisms (De Luca
et al. 2015; Huxtable 1992; Vitvitsky et al. 2011). Although
more studies are needed to fully understand how EtOH and
TAU interact, the mechanisms responsible for TAU effects on
behavior are mainly associated to the GABAergic and
glycinergic agonism (Dzirkale et al. 2011; Frosini et al.
2006), as well as to the antagonism of NMDA receptors
(Chan et al. 2014). Thus, the biphasic effect of TAU associa-
tion may involve complex interactions of molecules with a
certain receptor and/or regulatory neurochemical pathways
(Calabrese and Baldwin 2001; Fontana et al. 2016; Fontana
et al. 2018; Rosemberg et al. 2012).
Interestingly, EtOH did change the responses across time
for the time spent in the top area and in the lit area, suggesting
that EtOH suppresses the natural decrease of anxiety across
time. However, although TAU increased the time spent in the
lit area, no significant effect of TAU across time was observed
for both anxiety-related tasks (novel tank and light-dark test).
Analyzing the interaction of the three factors (time, TAU, and
EtOH), a significant effect was observed. Altogether, these
data suggest that TAUwhen associated to EtOH has a positive
interaction across time and may attenuate alcohol suppressing
the natural zebrafish behavioral response.
PCA analysis of the light-dark supported that both TAU 42
and 400 groups are significantly affecting anxiety-related pa-
rameters (PC1). Alcohol anxiolytic-like responses were also
mainly observed in the light-dark test through the analysis of
the PC1. For the novel tank, the PC1 was related to locomo-
tion and PC2 to anxiety-related parameters. EtOH 1% clearly
induced locomotor deficits, and this could be an important
factor underlying alcohol-induced changes in anxiety-like
phenotypes. TAU 150 counteracted the anxiolytic-like effects
of EtOH 0.25%, and all TAU concentrations reduced locomo-
tor and anxiogenic effects of EtOH 1%. Overall, TAU alone
and associated to EtOH 0.25% presented a U-shaped profile
for anxiolytic-like behavior in the light-dark test, and all TAU
concentrations prevented anxiogenic-like responses in the
novel tank diving test. These data suggest that the behavioral
responses measured here reflect a complex interaction be-
tween both molecules.
The association of TAU with EtOH suggests a complex
interaction with different behavioral domains (e.g., aggres-
sion, anxiety, and locomotion). This association leads to a
U-shaped response in scototaxis-, aggression-, and anti-
predatory-like responses (Fontana et al. 2016). Importantly, a
dose-response is observed for other behavioral domains, such
as locomotion, anxiety (novel tank), and social behavior
(Fontana et al. 2018). To date, TAU 150 mg/L associated to
EtOH has positive effects in the light-dark test and aggressive-
ness. All TAU concentrations also reduced EtOH-induced lo-
comotor deficits, suggesting a protective role of TAU in this
specific behavior. However, concomitant alcohol and 400 mg/
L TAU exposure potentiates aggression in the mirror-induced
aggression test (Fontana et al. 2016) and decreases the prefer-
ence for conspecifics (Fontana et al. 2018). Because alcohol
disinhibits punished behavior (Fillmore et al. 2008; Johansson
and Hansen 2000), concomitant exposure to TAU and EtOH
may have more dangerous impact since TAU also decreased
the time close to the predator (Fontana et al. 2018).
Although the mechanisms underlying the modulatory role
of TAU on EtOH-induced behaviors in zebrafish are still un-
clear, the complex behavioral effects observed in the presence
of both molecules reinforce the involvement of different neu-
rotransmitter systems. Further studies are needed to investi-
gate how TAU and EtOH interact each other. Importantly, the
dissociable patterns of behavior observed for the light-dark vs
novel tank tests were previously reported (Maximino et al.
2010b; Blaser and Rosemberg 2012), suggesting that both
tests are complementary rather than interchangeable and in-
volve different motivational aspects.
Conclusions
In summary, our novel findings demonstrate that TAU shows
a biphasic profile when co-exposed with EtOH, where low
and high TAU concentrations decrease anxiety and do not
prevent alcohol-mediated anxiolysis. Meanwhile, the interme-
diate TAU concentration did not change anxiety-related pa-
rameters and has a protective effect against EtOH 0.25%-in-
duced behavioral changes. Moreover, all TAU concentrations
prevented against sedative effects of alcohol by decreasing
anxiogenic-like behavior and reducing locomotor deficits.
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Overall, TAU and EtOH concomitant exposure have complex
behavioral outcomes against alcohol-induced anxiolytic and
anxiogenic-like phenotypes, and care should be taken with
their simultaneous use. Furthermore, more studies are neces-
sary to investigate the mechanisms underlining how TAU ex-
posure differently modulates EtOH-induced anxiolytic and
anxiogenic phenotypes.
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